You have 9 free searches left this month | to do more

fruquintinib

Fruquintinib is a drug used to treat Colorectal Cancer, NSCLC, Advanced Colorectal Carcinoma, and other conditions. Fruquintinib is being actively studied in 14 studies and prior, has been studied in 10.

Top SponsorsTop SitesTop Investigators
Hutchison Medipharma LimitedBeijing Cancer HospitalWeijian Guo
Fudan UniversityFudan University Shanghai Cancer CenterDai, Guanghai
Genor Biopharma Co., Ltd.Guangdong General HospitalShen Lin
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Recruiting
  • Advanced Colorectal Carcinoma
  • Fruquintinib and raltitrexed
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
2021-10-18
Oct 18, 2021
H
Not yet recruiting
  • Hepatic Impairment
  • Fruquintinib
  • (no location specified)
2022-02-08
Feb 8, 2022
H
Not yet recruiting
  • Renal Impairment
  • Fruquintinib
  • (no location specified)
2022-02-08
Feb 8, 2022
F
Recruiting
  • Soft Tissue Sarcoma
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-03-01
Mar 1, 2022
T
Recruiting
  • Colorectal Neoplasms
  • hypofractionation Radiotherapy
  • +3 more
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
2022-03-28
Mar 28, 2022
F
Not yet recruiting
  • Advanced Pancreatic Carcinoma
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-02-16
Feb 16, 2022
S
Recruiting
  • Colo-rectal Cancer
  • Fruquintinib
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
2021-11-01
Nov 1, 2021
H
Completed
  • Drug Drug Interaction
  • Fruquintinib
  • +2 more
  • Cypress, California
    WCCT
2021-06-16
Jun 16, 2021
G
Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai chest hospital
2021-03-02
Mar 2, 2021
G
Recruiting
  • Metastatic Colorectal Cancer
  • Geptanolimab Injection
  • Fruquintinib
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
2021-02-08
Feb 8, 2021
H
Recruiting
  • Triple Negative Breast Cancer
  • Springdale, Arkansas
  • +2 more
2021-07-07
Jul 7, 2021
F
Recruiting
  • Metastatic Colorectal Cancer
  • Stereotactic Ablative Radiotherapy (SABR)
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2021-08-23
Aug 23, 2021
B
Recruiting
  • Advanced Solid Tumors
  • Fuzhou, Fujian, China
  • +8 more
2021-05-06
May 6, 2021
P
Recruiting
  • Colorectal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2020-06-11
Jun 11, 2020
H
Completed
  • Food Effect of Fruquintinib in Health Subjects
  • fruquintinib
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
2020-02-13
Feb 13, 2020
H
Completed
  • Colorectal Cancer
  • fruquintinib
  • placebo
  • Beijing, Beijing, China
  • +4 more
2020-06-12
Jun 12, 2020
H
Completed
  • Healthy
  • fruquintinib
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
2020-02-12
Feb 12, 2020
H
Completed
  • Colorectal Cancer
  • fruquintinib
  • Guangzhou, Guangdong, China
  • +1 more
2020-02-13
Feb 13, 2020
C
Unknown status
  • Metastasis Colorectal Cancer
  • Beijing, China
    China PLAGH
2019-11-25
Nov 25, 2019
H
Withdrawn
  • Lung Cancer
  • Fruquintinib
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
2019-11-17
Nov 17, 2019
H
Completed
  • Non-small Cell Lung Cancer
  • Fruquintinib
  • Placebo
  • Beijing, Beijing, China
  • +11 more
2020-02-12
Feb 12, 2020
S
Unknown status
  • Biliary Tract Adenocarcinoma
  • Fruquintinib
  • Beijing, Beijing, China
  • +6 more
2019-11-06
Nov 6, 2019
H
Completed
  • Colorectal Cancer
  • fruquintinib
  • placebo
  • Hefei, Anhui, China
  • +14 more
2020-02-13
Feb 13, 2020
H
Completed
  • Tumor
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
2020-02-13
Feb 13, 2020